BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 36899609)

  • 1. Global dynamics of IAV/SARS-CoV-2 coinfection model with eclipse phase and antibody immunity.
    Elaiw AM; Alsulami RS; Hobiny AD
    Math Biosci Eng; 2023 Jan; 20(2):3873-3917. PubMed ID: 36899609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coinfection with SARS-CoV-2 and Influenza A Virus Increases Disease Severity and Impairs Neutralizing Antibody and CD4
    Kim EH; Nguyen TQ; Casel MAB; Rollon R; Kim SM; Kim YI; Yu KM; Jang SG; Yang J; Poo H; Jung JU; Choi YK
    J Virol; 2022 Mar; 96(6):e0187321. PubMed ID: 35107382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets.
    Huang Y; Skarlupka AL; Jang H; Blas-Machado U; Holladay N; Hogan RJ; Ross TM
    J Virol; 2022 Mar; 96(5):e0179121. PubMed ID: 34936487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of influenza A virus and SARS-CoV-2 infection or co-infection by griffithsin and griffithsin-based bivalent entry inhibitor.
    Cao N; Cai Y; Huang X; Jiang H; Huang Z; Xing L; Lu L; Jiang S; Xu W
    mBio; 2024 May; 15(5):e0074124. PubMed ID: 38587427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-infection of SARS-COV-2 and Influenza A Virus: A Case Series and Fast Review.
    Xiang X; Wang ZH; Ye LL; He XL; Wei XS; Ma YL; Li H; Chen L; Wang XR; Zhou Q
    Curr Med Sci; 2021 Feb; 41(1):51-57. PubMed ID: 33582905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral Interference During Influenza A-SARS-CoV-2 Coinfection of the Human Airway Epithelium and Reversal by Oseltamivir.
    Cheemarla NR; Watkins TA; Mihaylova VT; Foxman EF
    J Infect Dis; 2024 May; 229(5):1430-1434. PubMed ID: 37722683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential Infection with Influenza A Virus Followed by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads to More Severe Disease and Encephalitis in a Mouse Model of COVID-19.
    Clark JJ; Penrice-Randal R; Sharma P; Dong X; Pennington SH; Marriott AE; Colombo S; Davidson A; Kavanagh Williamson M; Matthews DA; Turtle L; Prince T; Hughes GL; Patterson EI; Shawli G; Mega DF; Subramaniam K; Sharp J; Turner JD; Biagini GA; Owen A; Kipar A; Hiscox JA; Stewart JP
    Viruses; 2024 May; 16(6):. PubMed ID: 38932155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global dynamics of SARS-CoV-2/malaria model with antibody immune response.
    Agha ADA; Elaiw AM
    Math Biosci Eng; 2022 Jun; 19(8):8380-8410. PubMed ID: 35801470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How Interactions during Viral-Viral Coinfection Can Shape Infection Kinetics.
    Pinky L; DeAguero JR; Remien CH; Smith AM
    Viruses; 2023 May; 15(6):. PubMed ID: 37376603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection.
    Oishi K; Horiuchi S; Minkoff JM; tenOever BR
    J Virol; 2022 Aug; 96(15):e0076522. PubMed ID: 35862681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza A and Respiratory Syncytial Virus Trigger a Cellular Response That Blocks Severe Acute Respiratory Syndrome Virus 2 Infection in the Respiratory Tract.
    Dee K; Schultz V; Haney J; Bissett LA; Magill C; Murcia PR
    J Infect Dis; 2023 Jun; 227(12):1396-1406. PubMed ID: 36550077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity.
    Achdout H; Vitner EB; Politi B; Melamed S; Yahalom-Ronen Y; Tamir H; Erez N; Avraham R; Weiss S; Cherry L; Bar-Haim E; Makdasi E; Gur D; Aftalion M; Chitlaru T; Vagima Y; Paran N; Israely T
    Nat Commun; 2021 Oct; 12(1):5819. PubMed ID: 34611155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability analysis of within-host SARS-CoV-2/HIV coinfection model.
    Al Agha AD; Elaiw AM; Azoz SA; Ramadan E
    Math Methods Appl Sci; 2022 Jun; ():. PubMed ID: 35942149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of SARS-CoV-2 and influenza A virus (H1N1) coinfection in dead patients in Northeastern Iran.
    Hashemi SA; Safamanesh S; Ghasemzadeh-Moghaddam H; Ghafouri M; Azimian A
    J Med Virol; 2021 Feb; 93(2):1008-1012. PubMed ID: 32720703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 and influenza virus coinfection among patients with severe acute respiratory infection during the first wave of COVID-19 pandemic in Bangladesh: a hospital-based descriptive study.
    Akhtar Z; Islam MA; Aleem MA; Mah-E-Muneer S; Ahmmed MK; Ghosh PK; Rahman M; Rahman MZ; Sumiya MK; Rahman MM; Shirin T; Alamgir ASM; Banu S; Rahman M; Chowdhury F
    BMJ Open; 2021 Nov; 11(11):e053768. PubMed ID: 34845073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters.
    Zhang AJ; Lee AC; Chan JF; Liu F; Li C; Chen Y; Chu H; Lau SY; Wang P; Chan CC; Poon VK; Yuan S; To KK; Chen H; Yuen KY
    Clin Infect Dis; 2021 Jun; 72(12):e978-e992. PubMed ID: 33216851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct inhibitory effect on viral entry of influenza A and SARS-CoV-2 viruses by azithromycin.
    Du X; Zuo X; Meng F; Han C; Ouyang W; Han Y; Gu Y; Zhao X; Xu F; Qin FX
    Cell Prolif; 2021 Jan; 54(1):e12953. PubMed ID: 33211371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coinfection with influenza A virus enhances SARS-CoV-2 infectivity.
    Bai L; Zhao Y; Dong J; Liang S; Guo M; Liu X; Wang X; Huang Z; Sun X; Zhang Z; Dong L; Liu Q; Zheng Y; Niu D; Xiang M; Song K; Ye J; Zheng W; Tang Z; Tang M; Zhou Y; Shen C; Dai M; Zhou L; Chen Y; Yan H; Lan K; Xu K
    Cell Res; 2021 Apr; 31(4):395-403. PubMed ID: 33603116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Virus on Human Skin: Importance of Hand Hygiene in Coronavirus Disease 2019 (COVID-19).
    Hirose R; Ikegaya H; Naito Y; Watanabe N; Yoshida T; Bandou R; Daidoji T; Itoh Y; Nakaya T
    Clin Infect Dis; 2021 Dec; 73(11):e4329-e4335. PubMed ID: 33009907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequential infections with rhinovirus and influenza modulate the replicative capacity of SARS-CoV-2 in the upper respiratory tract.
    Essaidi-Laziosi M; Alvarez C; Puhach O; Sattonnet-Roche P; Torriani G; Tapparel C; Kaiser L; Eckerle I
    Emerg Microbes Infect; 2022 Dec; 11(1):412-423. PubMed ID: 34931581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.